SCHEMBL1994337

SCHEMBL1994337

CCN(CC)CCCS(=O)(=O)N[C@H](CCc1ccccc1)c1nc(-c2ccccc2OC)no1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 1/20 0.57
RXFP1 Q9HBX9 1/20 0.38
SMN1; SMN2 Q16637 4/20 0.38
ALDH1A1 P00352 4/20 0.38
RAB9A P51151 3/20 0.38
L3MBTL1 Q9Y468 3/20 0.38
NPC1 O15118 3/20 0.38
TP53 P04637 2/20 0.38
CA2 P00918 2/20 0.37
CA9 Q16790 2/20 0.37
S1PR1 P21453 1/20 0.37
HPGD P15428 3/20 0.36
HSD17B10 Q99714 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
KDM4E B2RXH2 1/20 0.36
BCHE P06276 2/20 0.36
TSHR P16473 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
POLB P06746 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1991192 0.88 GHSR (0.52) GHSRSMN1; SMN2ALDH1A1RAB9ANPC1
SCHEMBL1989714 0.87 GHSR (0.72) GHSRSMN1; SMN2ALDH1A1RAB9AL3MBTL1
SCHEMBL1993938 0.87 GHSR (0.51) GHSRSMN1; SMN2RAB9AL3MBTL1NPC1
SCHEMBL1990715 0.86 GHSR (0.58) GHSRL3MBTL1NPC1S1PR1NPSR1
SCHEMBL1994348 0.86 GHSR (0.54) GHSRALDH1A1L3MBTL1BCHETSHR
SCHEMBL1994990 0.84 GHSR (0.50) GHSRALDH1A1L3MBTL1TP53S1PR1
SCHEMBL1986905 0.83 GHSR (0.58) GHSRL3MBTL1S1PR1TSHRLMNA
SCHEMBL1992742 0.83 GHSR (0.49) GHSRTP53S1PR1TSHRGAA
SCHEMBL1990054 0.82 GHSR (0.54) GHSRALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL1988077 0.82 GHSR (0.55) GHSRALDH1A1L3MBTL1POLBGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110152232-A1 SULFONAMIDE COMPOUNDS AND USES THEREOF SAUNDERS JEFFREY O 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152232-A1 SULFONAMIDE COMPOUNDS AND USES THEREOF GHSR, GHRHR, SSTR2 GHSR 1/4885RXFP1 179/4885SMN1; SMN2 1606/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.